Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Generex Biotechnology Corporatio (GNBT)

Generex Biotechnology Corporatio (GNBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 22,648
  • Shares Outstanding, K 106,931
  • Annual Sales, $ 6,200 K
  • Annual Income, $ -9,340 K
  • 60-Month Beta -2.90
  • Price/Sales 36.53
  • Price/Cash Flow N/A
  • Price/Book 15.02
Trade GNBT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.34
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/10/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1870 +5.61%
on 10/02/20
0.2700 -26.85%
on 10/13/20
-0.0360 (-15.42%)
since 09/29/20
3-Month
0.1650 +19.70%
on 09/24/20
0.5400 -63.43%
on 07/30/20
-0.3240 (-62.13%)
since 07/29/20
52-Week
0.1429 +38.25%
on 12/23/19
1.6500 -88.03%
on 02/28/20
-0.0425 (-17.71%)
since 10/29/19

Most Recent Stories

More News
The Global Protein Therapeutics Market is expected to grow from USD 56,236.13 Million in 2018 to USD 91,756.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.24%

, /PRNewswire/ --The Global Protein Therapeutics Market is expected to grow from in 2018 to by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.24%. Read the full report: The positioning...

AMGN : 217.89 (+0.70%)
BAX : 78.04 (-0.14%)
LLY : 132.53 (+0.93%)
GNBT : 0.1968 (-7.08%)
NVO : 66.33 (-0.33%)
Advanced Drug Delivery Systems Market to Witness Huge Growth by 2025 |3M, Allergan PLC, Theraject

- The exploration report comprised with market data derived from primary as well as secondary research techniques. The points covered in this study are primarily factors which are considered to be market...

BAX : 78.04 (-0.14%)
GNBT : 0.1968 (-7.08%)
IAIC : 0.7000 (-11.39%)
MYL : 14.38 (+0.56%)
VRX.TO : 30.80 (-3.33%)
Why the U.S. is "Flying in the Dark" Without Quicker Ability to Diagnose COVID-19

It seems that every hour of every day recently, on the internet, in print and on TV more about the Coronavirus situation continues to grow. There is so much new data on the subject every minute. But that...

IBIO : 1.7700 (-3.80%)
HWKE : 0.5080 (+2.01%)
NVAX : 87.69 (+7.82%)
GNBT : 0.1968 (-7.08%)
VXRT : 5.31 (+6.20%)
Advanced Drug Delivery Systems Market Growing Opportunity 2020 to 2026

AGN : 193.02 (+0.02%)
BAX : 78.04 (-0.14%)
GNBT : 0.1968 (-7.08%)
MYL : 14.38 (+0.56%)
VRX.TO : 30.80 (-3.33%)
PFE : 35.23 (-0.62%)
MMM : 158.60 (+0.04%)
Generex Biotechnology Discusses Coronavirus Solutions with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - February 6, 2020) - The Stock Day Podcast welcomed Generex Biotechnology (OTCQB: GNBT) ("the Company"), an integrated healthcare holding company with end-to-end solutions...

GNBT : 0.1968 (-7.08%)
The Comprehensive Study on About Global Advanced Drug Delivery Systems Market 2020 by Growth Factors, Applications, Regional Analysis, Key Players like

BAX : 78.04 (-0.14%)
GNBT : 0.1968 (-7.08%)
MYL : 14.38 (+0.56%)
VRX.TO : 30.80 (-3.33%)
Generex Biotechnology Appoints Independent Directors Craig Eagle, MD and Thomas Leonard to the NuGenerex Immuno-Oncology Board of Directors

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is proud to announce the appointments of Dr. Craig Eagle, MD and Mr. Thomas Leonard to the...

PFE : 35.23 (-0.62%)
GNBT : 0.1968 (-7.08%)
Generex Biotechnology Appoints Independent Director Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology Board of Directors

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is proud to announce the appointment of Dr. Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology...

GNBT : 0.1968 (-7.08%)
Generex Biotechnology Corporation Discusses Upcoming Revenue Increases and Growth with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - October 7, 2019) - The Stock Day Podcast welcomed Generex Biotechnology Corporation (OTCQB: GNBT) ("the Company"), an integrated healthcare holding company with end-to-end...

GNBT : 0.1968 (-7.08%)
Generex Engages Donohoe Advisory to Assist with Uplisting

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that Generex has engaged Donohoe Advisory Associates LLC ("Donohoe Advisory")...

GNBT : 0.1968 (-7.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

2nd Resistance Point 0.2281
1st Resistance Point 0.2199
Last Price 0.1968
1st Support Level 0.1987
2nd Support Level 0.1857

See More

52-Week High 1.6500
Fibonacci 61.8% 1.0743
Fibonacci 50% 0.8964
Fibonacci 38.2% 0.7186
Last Price 0.1968
52-Week Low 0.1429

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar